Carboxyterminal propeptide of type I procollagen in osteomalacia
- PMID: 7953986
- DOI: 10.1007/BF00297181
Carboxyterminal propeptide of type I procollagen in osteomalacia
Abstract
Carboxyterminal propeptide of type I procollagen (PICP) was measured in sera from 25 patients with osteomalacia due to privational vitamin D deficiency. The mean value of serum PICP was significantly raised in patients with osteomalacia compared with 40 normal subjects (mean +/- SD, 161 +/- 82 ng/ml and 113 +/- 31 ng/ml, respectively; P = 0.01). The raised serum PICP reflected the accelerated bone turnover in this condition as did the elevated serum total alkaline phosphatase (ALP), but the variation in values of serum PICP noted in individual patients may reflect the different stages of osteomalacia. The normalization of serum PICP and ALP, indicating a healing process of the bone disorder, needed longer time of vitamin D and calcium therapy. In contrast, adjusted serum calcium and inorganic phosphate (IP) responded and normalized rapidly. Serum PICP and total ALP appeared to behave differently in the disease and in its response to vitamin D therapy suggesting that these two markers may represent different functions of osteoblasts in osteomalacia.
Similar articles
-
Serum levels of bone-specific alkaline phosphatase and procollagen type I carboxyterminal peptide in vitamin D deficiency.Southeast Asian J Trop Med Public Health. 2002;33 Suppl 2:124-30. Southeast Asian J Trop Med Public Health. 2002. PMID: 12755282
-
Characteristics of biochemical markers in patients with metabolic bone disorders.Endocr Res. 1998 Feb;24(1):55-64. doi: 10.3109/07435809809031868. Endocr Res. 1998. PMID: 9553754
-
Bone turnover in children with vitamin D deficiency rickets before and during treatment.Acta Paediatr. 2000 May;89(5):513-8. doi: 10.1080/080352500750027763. Acta Paediatr. 2000. PMID: 10852183
-
Clinical usefulness of serum carboxyterminal propeptide of type I procollagen and pyridinoline cross-linked carboxyterminal telopeptide of type I collagen in patients with prostate cancer.Jpn J Clin Oncol. 1996 Jun;26(3):157-63. doi: 10.1093/oxfordjournals.jjco.a023200. Jpn J Clin Oncol. 1996. PMID: 8656556
-
[Carboxy-terminal propeptide of type I procollagen (PICP)].Nihon Rinsho. 2004 Dec;62 Suppl 12:244-6. Nihon Rinsho. 2004. PMID: 15658310 Review. Japanese. No abstract available.
Cited by
-
High bone mineral density in pycnodysostotic patients with a novel mutation in the propeptide of cathepsin K.Osteoporos Int. 2007 May;18(5):659-69. doi: 10.1007/s00198-006-0311-y. Epub 2007 Jan 6. Osteoporos Int. 2007. PMID: 17206399
-
Early increase of bone resorption in patients with liver cirrhosis secondary to viral hepatitis.Dig Dis Sci. 2000 Jul;45(7):1392-9. doi: 10.1023/a:1005568406664. Dig Dis Sci. 2000. PMID: 10961720
-
How does bone recover in patients with tumor-induced osteomalacia? Long-term follow-up in a national cohort study.JBMR Plus. 2025 Apr 14;9(5):ziaf041. doi: 10.1093/jbmrpl/ziaf041. eCollection 2025 May. JBMR Plus. 2025. PMID: 40260218 Free PMC article.
-
Collagenous and non-collagenous biochemical markers of bone metastases from prostate cancer.Hippokratia. 2010 Jul;14(3):164-9. Hippokratia. 2010. PMID: 20981164 Free PMC article.